The updated deal for pharmacists will help recognise their role as health experts, not just retailersCommunity Pharmacy Agreement • February 17th, 2024
Australia's 7th Community Pharmacy Agreement, which comes into force today and lasts five years, will see the government provide A$16 billion for dispensing subsidized medicines and A$1.15 billion for other
Sixth Community Pharmacy AgreementCommunity Pharmacy Agreement • November 29th, 2020
THE FIFTH COMMUNITY PHARMACY AGREEMENTCommunity Pharmacy Agreement • August 3rd, 2020
ContractCommunity Pharmacy Agreement • April 23rd, 2021
Turning Point Supervised Consumption of Opioid Substitution Treatments and other medication Pharmacy Specification
Turning Point Specification for Needle & Syringe Programme SDAS Community Pharmacy Agreement (Part B) V1.0 April 2019Community Pharmacy Agreement • February 11th, 2019
This document sets out a Service Specification for a community pharmacy ‘Needle & Syringe Programme’ (NSP) to be provided by the Contractor1 to service users across the Somerset Drug and Alcohol Service (SDAS). The practice is designed to reduce harm to people who inject drugs (PWID) and in turn reduce the prevalence of blood-borne viruses and bacterial infections. The safe disposal of used equipment will also benefit the wider community.
TERMS OF REFERENCECommunity Pharmacy Agreement • April 27th, 2017
The Sixth Community Pharmacy Agreement (6CPA) is a five-year agreement between the Australian Government and the Pharmacy Guild of Australia, established under the auspices of the National Health Act 1953, that governs, amongst other things, the remuneration arrangements for approved pharmacists for the supply of medicines listed on the Pharmaceutical Benefits Scheme.
Turning Point Specification for Community Pharmacy Take Home Naloxone (THN) Programme SDAS Community Pharmacy Agreement (Part A) V1.0 April 2019Community Pharmacy Agreement • April 21st, 2020 • England
AN AGREEMENT BETWEEN Turning Point, Standon House, 21 Mansell Street, London E1 8AA (hereinafter referred to as 'Company') and the person, firm or company shown in Schedule A (hereinafter referred to as ‘Contractor’)
Seventh Community Pharmacy AgreementCommunity Pharmacy Agreement • June 11th, 2020
The Signatories to this Agreement are The Honourable Greg Hunt MP, Minister for Health on behalf of the Commonwealth of Australia and the Pharmacy Guild of Australia.
ContractCommunity Pharmacy Agreement • March 27th, 2017
The sixth community pharmacy agreement (6CPA) has been signed and came into effect on 1 July. While, at the time of writing, not all of the details were known, enough was known to realise that the 6CPA would present an entirely new set of cobblestones that would challenge the ‘traditional’ model of community pharmacy.
SIXTHCommunity Pharmacy Agreement • May 25th, 2015
The 6CPA General Terms and Conditions are currently available in draft form and will shortly be updated to comply with the Commonwealth Grants Rules and Guidelines. Updates to these terms and conditions will not change the intent of the programmes, but will provide additional clarity for participants. The programmes will continue to operate under these draft terms and conditions until updated terms and conditions are published.
Pharmacy agreement updated but not upgradedCommunity Pharmacy Agreement • June 23rd, 2020
Australian patients and taxpayers will contribute more than $25 billion over five years under the new Community Pharmacy Agreement yet consumers have little effective say in this central part of the health system.
Eighth Community Pharmacy AgreementCommunity Pharmacy Agreement • June 2nd, 2024
Name The Hon Mark Butler MP, Minister for Health and Aged Care on behalf of the Commonwealth of Australia Short name Commonwealth
COMMERCIAL IN CONFIDENCECommunity Pharmacy Agreement • October 13th, 2015
• $650 million to support trials and new and expanded programs delivered through community pharmacy (ex unapproved pharmacies)
retail managementCommunity Pharmacy Agreement • September 26th, 2005
Specification for Supervised ConsumptionCommunity Pharmacy Agreement • March 24th, 2016
This document sets out a service specification for a community pharmacy ‘supervised consumption’ service to be provided by the contractor to service users who are prescribed methadone or buprenorphine and will encompass supervised support and advice to service users in a safe environment. The practice is designed to support service users to stop or stabilise their opiate use thus enabling them to develop their personal goals.
Take advantage of Government IncentivesCommunity Pharmacy Agreement • June 2nd, 2011
The current (Fifth) Community Pharmacy Agreement has allocated $663 million of funding for the provision of professional services by community pharmacies.
6th Community Pharmacy Agreement (effective 1st July 2015)Community Pharmacy Agreement • July 3rd, 2015
Programme Name 5CPA $m Year 1 of6CPA $m Years 2-5of 6CPA $m Total 6CPA$m Medication Adherence Programmes:* 123.6 189.2 Dose Administration Aids (DAA) 132 58.4 * * Staged Supply 35 7.2 * * Medication Management Programmes:* 114.9 178.3 Clinical Interventions 97 19.8 * * Home Medicine Reviews 52.11 14.5 * * Residential Medication ManagementReviews 70 14.2 * * MedsCheck 29.6 14.9 * * Diabetes MedsCheck (5CPA only) 12.2 Pharmacy Practice Incentive &Accreditation (5CPA only) 75 Pharmacy Trial Program (PTP) in 6CPA * 50 * 650* Aboriginal & Torres Strait IslanderProgrammes 28.9 6.1 33.9 40.0 Rural Support Programmes 107 21.2 99.1 120.3 eHealth: 12.7 48.3 61.0 Electronic Prescription Fee (EPF) 12.7 * * Other activity# 24.6 8.3 15.9 24.2 Total 663.4 227.3 1,263*
Third Community Pharmacy AgreementCommunity Pharmacy Agreement • February 7th, 2023
Turning Point Specification for Needle & Syringe Programme ROAR Community Pharmacy Agreement (Part B) V1.0 March 2018Community Pharmacy Agreement • August 20th, 2021
This document sets out a service specification for a community pharmacy ‘needle & syringe programme’ (NSP) to be provided by the contractor to service users across the Rochdale and Oldham Active Recovery (ROAR) Service. The practice is designed to reduce harm to people who inject drugs (PWID) and in turn reduce the prevalence of blood-borne viruses and bacterial infections. The safe disposal of used equipment will also benefit the wider community.
IntroductionCommunity Pharmacy Agreement • November 19th, 2015
$45 billion, to help maintain a national network of approximately 5,460 retail pharmacies as the primary means of dispensing PBS medicines to the public. The Government has also used the agreements to fund
